National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Xadago® for the treatment of adult patients with idiopathic Parkinson’s disease.

 

Rapid Review

Commenced Completed Outcome
14/06/2016 06/07/2016 Reimbursement not recommended.